LifeMD, Inc.

LifeMD, Inc.

LFMD·NASDAQ

$4.56

+2.8%
HealthcareMedical - Pharmaceuticals

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

At a Glance

Live Snapshot
Market Cap$220.53M
EPS-0.2300
P/E Ratio-19.83
Earnings Date08/04/2026
-26.02%
Return on Invested Capital
-66%
3Y-101.0%
5Y-100.0%
10Y-103.0%
-30.69%
Return on Equity
-109%
3Y-105.0%
5Y-99.0%
10Y-110.0%
-10.09%
Return on Assets
-61%
3Y-94.0%
5Y-98.0%
10Y-93.0%
LifeMD, Inc.

LifeMD, Inc. Management Team

LFMD · NASDAQ
MJ

Mr. Justin Schreiber

Chairman & Chief Executive Officer

Compensation

$803,459

Born 1983(Age 43)
male
MM

Ms. Maria E. Stan CPA

Chief Accounting Officer & Controller

Born 1975(Age 51)
female
MN

Mr. Nicholas P. Alvarez

Chief Acquisition Officer & Head of Customer Acquisition

Compensation

$141,110

Born 1982(Age 44)
male
MS

Mr. Shane Biffar

Chief Compliance Officer & Deputy General Counsel

Compensation

$411,558

Born 1983(Age 43)
male
MM

Mr. Marc Benathen

Chief Financial Officer

Compensation

$608,728

Born 1981(Age 45)
male
MS

Mr. Stefan Galluppi

Chief Innovation Officer

Compensation

$585,284

Born 1987(Age 39)
male
ME

Mr. Eric H. Yecies

Chief Legal Officer, General Counsel & Corporate Secretary

Compensation

$332,000

Born 1978(Age 48)
male
MJ

Ms. Jessica Friedeman

Chief Marketing Officer

Born 1984(Age 42)
female
MD

Mr. Dennis Wijnker

Chief Technology Officer

Compensation

$540,873

Born 1976(Age 50)
male
MJ

Mr. James Porte

Senior Vice President of Patient Experience

male
lfmd

LifeMD, Inc. Insider Positioning

LFMD · NASDAQ

During the last 12 months, insiders have sold $4.00M worth of LFMD shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

0

0.00

Sold

15.0K

54.16K

Net Activity

-54K

-$54K

6-9 Months

Bought

0

0.00

Sold

75.0K

443.76K

Net Activity

-444K

-$444K

9-12 Months

Bought

0

0.00

Sold

275.0K

3.50M

Net Activity

-3.5M

-$3.50M

Top Buyers

No buying activity

Top Sellers

1
BMD

Benathen Marc David

Officer: Chief Financial Officer

125.0K shares2 transactions

$1.68M

2
GS

Galluppi Stefan

Officer: Chief Innovation Officer

85.0K shares1 transactions

$1.05M

3
SJ

Schreiber Justin

Director, Officer: Chairman And Ceo

50.0K shares2 transactions

$584K

4
ANP

Alvarez Nicholas P

Officer: Chief Acquisition Officer

75.0K shares1 transactions

$444K

5
YEH

Yecies Eric Harold

Officer: Chief Legal Officer & Gc

15.0K shares1 transactions

$184K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $4.00M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Insider Participation

High Selling

5 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

SEC Filings

LFMD - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2026

N/A

April 30, 2026
April 30, 2026
2026
DEF 14A

DEF 14A 2025

N/A

April 28, 2025
April 28, 2025
2025
DEF 14A

DEF 14A 2023

N/A

April 29, 2024
December 31, 2023
2023
DEF 14A

DEF 14A 2023

N/A

April 28, 2023
April 28, 2023
2023
DEF 14A

DEF 14A 2022

N/A

April 29, 2022
April 29, 2022
2022
DEF 14A

DEF 14A 2021

N/A

May 12, 2021
May 12, 2021
2021
DEF 14A

DEF 14A 2020

N/A

December 07, 2020
December 07, 2020
2020
DEF 14A

DEF 14A 2020

N/A

December 16, 2019
January 10, 2020
2020
DEF 14A

DEF 14A 2018

N/A

April 20, 2018
May 24, 2018
2018
Showing 1 to 9 of 9 filings